$203 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 77 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EMKR | Buy | Emcore Corp. | $22,224,000 | +1.0% | 3,625,415 | +12.1% | 10.92% | -7.7% |
| TLGT | New | Teligent, Inc. | $17,031,000 | – | 1,913,545 | +100.0% | 8.37% | – |
| XENT | Buy | Intersect ENT Inc. | $12,563,000 | +22.4% | 558,339 | +27.2% | 6.18% | +11.8% |
| NEO | Buy | NeoGenomics Inc. | $12,337,000 | +37.7% | 1,567,526 | +0.3% | 6.06% | +25.9% |
| GIMO | Buy | Gigamon Inc. | $7,564,000 | +47.1% | 284,695 | +10.8% | 3.72% | +34.5% |
| IL | Buy | IntraLinks Holdings Inc. | $5,915,000 | +14.1% | 652,135 | +4.2% | 2.91% | +4.3% |
| OMCL | Buy | Omnicell Inc. | $3,898,000 | +1.3% | 125,417 | +1.3% | 1.92% | -7.4% |
| NXTM | Buy | NxStage Medical, Inc. | $3,716,000 | +58.4% | 169,612 | +14.0% | 1.83% | +44.8% |
| VG | Buy | Vonage Holdings Corp. | $1,961,000 | +148.9% | 341,595 | +154.8% | 0.96% | +127.4% |
| CVLT | Buy | CommVault Systems Inc. | $1,563,000 | +43.7% | 39,716 | +24.0% | 0.77% | +31.3% |
| SPSC | New | SPS Commerce, Inc. | $1,353,000 | – | 19,264 | +100.0% | 0.66% | – |
| SCON | Buy | Superconductor Technologies, Inc. | $1,126,000 | -41.7% | 5,363,491 | +72.0% | 0.55% | -46.7% |
| SPY | Buy | SPDR Trust Ser 1tr unit | $958,000 | +13.6% | 4,700 | +6.8% | 0.47% | +4.0% |
| BMRN | New | BioMarin Pharmaceutical Inc. | $914,000 | – | 8,724 | +100.0% | 0.45% | – |
| TROW | Buy | T. Rowe Price | $811,000 | +3.6% | 11,350 | +0.8% | 0.40% | -5.2% |
| XOM | Buy | Exxon Mobil Corporation | $696,000 | +10.1% | 8,930 | +5.0% | 0.34% | +0.6% |
| IWO | New | iShares Russell 2000 Growthrus 2000 grw etf | $498,000 | – | 3,575 | +100.0% | 0.24% | – |
| GE | New | General Electric Co. | $253,000 | – | 8,120 | +100.0% | 0.12% | – |
| AAPL | Buy | Apple Inc. | $214,000 | +3.4% | 2,030 | +8.0% | 0.10% | -5.4% |
| LXRX | Buy | Lexicon Pharmaceuticals Inc. | $182,000 | +41.1% | 13,710 | +14.1% | 0.09% | +29.0% |
| EXAS | New | Exact Sciences Corporation | $131,000 | – | 14,140 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 26 | Q3 2019 | 8.2% |
| RTI Surgical Inc. | 26 | Q3 2019 | 6.0% |
| Omnicell Inc. | 26 | Q3 2019 | 4.7% |
| AtriCure Inc. | 26 | Q3 2019 | 4.6% |
| Ligand Pharmaceuticals Inc. | 26 | Q3 2019 | 4.5% |
| SPDR Trust Ser 1 | 26 | Q3 2019 | 2.3% |
| Marriott Intl. Inc. | 26 | Q3 2019 | 1.5% |
| Southwest Airls Co. | 26 | Q3 2019 | 1.3% |
| 3M Company | 26 | Q3 2019 | 1.2% |
| Aflac Incorporated | 26 | Q3 2019 | 1.1% |
View KOPP INVESTMENT ADVISORS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SUPERCONDUCTOR TECHNOLOGIES INC | August 19, 2016 | 528,963 | 16.6% |
| EMCORE CORP | April 01, 2016 | 1,248,970 | 4.8% |
| VITESSE SEMICONDUCTOR CORP | May 05, 2015 | ? | ? |
| TRANSGENOMIC INC | May 23, 2014 | 83,502 | 1.1% |
| RTI SURGICAL, INC. | January 03, 2014 | 1,984,618 | 3.5% |
| SYNERGETICS USA INC | January 03, 2014 | 877,253 | 3.5% |
| MINDSPEED TECHNOLOGIES, INC | December 13, 2013 | 2,068,416 | 4.8% |
| TRANSGENOMIC INC | November 01, 2013 | 13,744,086 | 15.6% |
| OCLARO, INC. | September 20, 2013 | 8,592,517 | 9.3% |
| SUPERCONDUCTOR TECHNOLOGIES INC | December 21, 2012 | 8,776,335 | 17.4% |
View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR/A | 2018-08-15 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-14 |
| 13F-HR | 2018-02-14 |
| 13F-HR | 2017-11-14 |
View KOPP INVESTMENT ADVISORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.